Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
bessemer venture partners
boehringer ingelheim
clinical trials
diabetes
diabetes type 2
eli lilly
empagliflozin
europe
europe blog main
europe top stories
fda
fractyl labs
funding
fundings & exits
general catalyst
google ventures
gv
health
ido fund
indiana blog main
indiana top stories
life sciences
mithril capital management
national blog main
new york blog main
new york top stories
science
slgt2 inhibitor
startups
tc
true ventures
type 1 diabetes
type 2 diabetes
What
diabetes
2
×
type
2
×
approval
associates
based
bessemer
bid
boehringer
capital
catalyst
deerfield
develop
developing
domain
drug
eli
emergent
expand
fallen
fda
financing
firms
fractyl
fund
general
gv
ido
including
ingelheim
l.p
labs
lexington
lilly
management
marketed
massachusetts
medical
medicine’s
million
mithril
Language
unset
Current search:
diabetes
×
biotech
×
type
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@techcrunch.com
6 years ago
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes
